Patient-reported outcome results from the open-label, randomized phase III myeloma X trial evaluating salvage autologous stem-cell transplantation in relapsed multiple myeloma

on behalf of the National Cancer Research Institute Haemato-Oncology Clinical Studies Group

Research output: Contribution to journalArticle (Academic Journal)peer-review

12 Citations (Scopus)
190 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Patient-reported outcome results from the open-label, randomized phase III myeloma X trial evaluating salvage autologous stem-cell transplantation in relapsed multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences